A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia

Irene Motta, Mirella Filocamo, Erika Poggiali, Marina Stroppiano, A. Dragani, Dario Consonni, Wilma Barcellini, Gianluca Gaidano, Luca Facchini, Giorgina Specchia, Maria Domenica Cappellini

Research output: Contribution to journalArticle

Abstract

Gaucher disease (GD) is the most common lysosomal disorder resulting from deficient activity of the β-glucosidase enzyme that causes accumulation of glucosylceramide in the macrophage-monocyte system. Notably, because of non-specific symptoms and a lack of awareness, patients with GD experience long diagnostic delays. The aim of this study was to apply a diagnostic algorithm to identify GD type 1 among adults subjects referred to Italian haematology outpatient units because of splenomegaly and/or thrombocytopenia and, eventually, to estimate the prevalence of GD in this selected population. One hundred and ninety-six subjects (61 females, 135 males; mean age 47.8 ± 18.2 years) have been enrolled in the study and tested for β-glucosidase enzyme activity on dried blood spot (DBS). Seven of 196 patients have been diagnosed with GD, (5 females and 2 males) with mean age 31.8 ± 8.2 years, with a prevalence of 3.6% (with a prevalence of 3.6% (I95% CI 1.4-7.2; 1/28 patients) in this population. These results show that the use of an appropriate diagnostic algorithm and a simple diagnostic method, such as DBS, are important tools to facilitate the diagnosis of a rare disease even for not disease-expert physicians.

Original languageEnglish
Pages (from-to)352-359
Number of pages8
JournalEuropean Journal of Haematology
Volume96
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Gaucher Disease
Splenomegaly
Thrombocytopenia
Multicenter Studies
Observational Studies
Early Diagnosis
Glucosidases
Glucosylceramides
Hematology
Enzymes
Rare Diseases
Population
Monocytes
Outpatients
Macrophages
Physicians

Keywords

  • Dried blood spot
  • Gaucher Disease
  • Splenomegaly
  • Thrombocytopenia
  • β-glucosidase

ASJC Scopus subject areas

  • Hematology

Cite this

A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia. / Motta, Irene; Filocamo, Mirella; Poggiali, Erika; Stroppiano, Marina; Dragani, A.; Consonni, Dario; Barcellini, Wilma; Gaidano, Gianluca; Facchini, Luca; Specchia, Giorgina; Cappellini, Maria Domenica.

In: European Journal of Haematology, Vol. 96, No. 4, 01.04.2016, p. 352-359.

Research output: Contribution to journalArticle

@article{2b8a541f089d40ff825dcb40143d38e0,
title = "A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia",
abstract = "Gaucher disease (GD) is the most common lysosomal disorder resulting from deficient activity of the β-glucosidase enzyme that causes accumulation of glucosylceramide in the macrophage-monocyte system. Notably, because of non-specific symptoms and a lack of awareness, patients with GD experience long diagnostic delays. The aim of this study was to apply a diagnostic algorithm to identify GD type 1 among adults subjects referred to Italian haematology outpatient units because of splenomegaly and/or thrombocytopenia and, eventually, to estimate the prevalence of GD in this selected population. One hundred and ninety-six subjects (61 females, 135 males; mean age 47.8 ± 18.2 years) have been enrolled in the study and tested for β-glucosidase enzyme activity on dried blood spot (DBS). Seven of 196 patients have been diagnosed with GD, (5 females and 2 males) with mean age 31.8 ± 8.2 years, with a prevalence of 3.6{\%} (with a prevalence of 3.6{\%} (I95{\%} CI 1.4-7.2; 1/28 patients) in this population. These results show that the use of an appropriate diagnostic algorithm and a simple diagnostic method, such as DBS, are important tools to facilitate the diagnosis of a rare disease even for not disease-expert physicians.",
keywords = "Dried blood spot, Gaucher Disease, Splenomegaly, Thrombocytopenia, β-glucosidase",
author = "Irene Motta and Mirella Filocamo and Erika Poggiali and Marina Stroppiano and A. Dragani and Dario Consonni and Wilma Barcellini and Gianluca Gaidano and Luca Facchini and Giorgina Specchia and Cappellini, {Maria Domenica}",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/ejh.12596",
language = "English",
volume = "96",
pages = "352--359",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia

AU - Motta, Irene

AU - Filocamo, Mirella

AU - Poggiali, Erika

AU - Stroppiano, Marina

AU - Dragani, A.

AU - Consonni, Dario

AU - Barcellini, Wilma

AU - Gaidano, Gianluca

AU - Facchini, Luca

AU - Specchia, Giorgina

AU - Cappellini, Maria Domenica

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Gaucher disease (GD) is the most common lysosomal disorder resulting from deficient activity of the β-glucosidase enzyme that causes accumulation of glucosylceramide in the macrophage-monocyte system. Notably, because of non-specific symptoms and a lack of awareness, patients with GD experience long diagnostic delays. The aim of this study was to apply a diagnostic algorithm to identify GD type 1 among adults subjects referred to Italian haematology outpatient units because of splenomegaly and/or thrombocytopenia and, eventually, to estimate the prevalence of GD in this selected population. One hundred and ninety-six subjects (61 females, 135 males; mean age 47.8 ± 18.2 years) have been enrolled in the study and tested for β-glucosidase enzyme activity on dried blood spot (DBS). Seven of 196 patients have been diagnosed with GD, (5 females and 2 males) with mean age 31.8 ± 8.2 years, with a prevalence of 3.6% (with a prevalence of 3.6% (I95% CI 1.4-7.2; 1/28 patients) in this population. These results show that the use of an appropriate diagnostic algorithm and a simple diagnostic method, such as DBS, are important tools to facilitate the diagnosis of a rare disease even for not disease-expert physicians.

AB - Gaucher disease (GD) is the most common lysosomal disorder resulting from deficient activity of the β-glucosidase enzyme that causes accumulation of glucosylceramide in the macrophage-monocyte system. Notably, because of non-specific symptoms and a lack of awareness, patients with GD experience long diagnostic delays. The aim of this study was to apply a diagnostic algorithm to identify GD type 1 among adults subjects referred to Italian haematology outpatient units because of splenomegaly and/or thrombocytopenia and, eventually, to estimate the prevalence of GD in this selected population. One hundred and ninety-six subjects (61 females, 135 males; mean age 47.8 ± 18.2 years) have been enrolled in the study and tested for β-glucosidase enzyme activity on dried blood spot (DBS). Seven of 196 patients have been diagnosed with GD, (5 females and 2 males) with mean age 31.8 ± 8.2 years, with a prevalence of 3.6% (with a prevalence of 3.6% (I95% CI 1.4-7.2; 1/28 patients) in this population. These results show that the use of an appropriate diagnostic algorithm and a simple diagnostic method, such as DBS, are important tools to facilitate the diagnosis of a rare disease even for not disease-expert physicians.

KW - Dried blood spot

KW - Gaucher Disease

KW - Splenomegaly

KW - Thrombocytopenia

KW - β-glucosidase

UR - http://www.scopus.com/inward/record.url?scp=84962799546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962799546&partnerID=8YFLogxK

U2 - 10.1111/ejh.12596

DO - 10.1111/ejh.12596

M3 - Article

VL - 96

SP - 352

EP - 359

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 4

ER -